Blocklisting Interim Review
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 10 May 2010
|
Name of applicant: |
GlaxoSmithKline plc |
|||
|
Name of scheme: |
GlaxoSmithKline Share Option Plan - Ordinary Shares |
|||
|
Period of return: |
From: |
1 November 2009 |
To: |
30 April 2010 |
|
Balance of unallotted securities under scheme(s) from previous return: |
5,027,516 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
0 |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
1,831,905 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
3,195,611 |
|||
|
Name of contact: |
Victoria Whyte |
|
Telephone number of contact: |
020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 10 May 2010
|
Name of applicant: |
GlaxoSmithKline plc |
|||
|
Name of scheme: |
GlaxoSmithKline Share Option Plan - ADS |
|||
|
Period of return: |
From: |
1 November 2009 |
To: |
30 April 2010 |
|
Balance of unallotted securities under scheme(s) from previous return: |
6,025,776 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
0 |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
841,634 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
5,184,142 |
|||
|
Name of contact: |
Victoria Whyte |
|
Telephone number of contact: |
020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 10 May 2010
|
Name of applicant: |
GlaxoSmithKline plc |
|||
|
Name of scheme: |
Glaxo Wellcome UK Share Option Scheme |
|||
|
Period of return: |
From: |
1 November 2009 |
To: |
30 April 2010 |
|
Balance of unallotted securities under scheme(s) from previous return: |
5,119,750 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
0 |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
0 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
5,119,750 |
|||
|
Name of contact: |
Victoria Whyte |
|
Telephone number of contact: |
020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 10 May 2010
|
Name of applicant: |
GlaxoSmithKline plc |
|||
|
Name of scheme: |
Glaxo Wellcome International Share Option Scheme |
|||
|
Period of return: |
From: |
1 November 2009 |
To: |
30 April 2010 |
|
Balance of unallotted securities under scheme(s) from previous return: |
13,267,156 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
0 |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
0 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
13,267,156 |
|||
|
Name of contact: |
Victoria Whyte |
|
Telephone number of contact: |
020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 10 May 2010
|
Name of applicant: |
GlaxoSmithKline plc |
|||
|
Name of scheme: |
Glaxo Wellcome 1999 Share Option Plan |
|||
|
Period of return: |
From: |
1 November 2009 |
To: |
30 April 2010 |
|
Balance of unallotted securities under scheme(s) from previous return: |
1,040,000 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
0 |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
0 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
1,040,000 |
|||
|
Name of contact: |
Victoria Whyte |
|
Telephone number of contact: |
020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 10 May 2010
|
Name of applicant: |
GlaxoSmithKline plc |
|||
|
Name of scheme: |
SmithKline Beecham 1989 Executive Share Option Plan - Approved - Ordinary Shares |
|||
|
Period of return: |
From: |
1 November 2009 |
To: |
30 April 2010 |
|
Balance of unallotted securities under scheme(s) from previous return: |
163,606 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
0 |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
0 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
163,606 |
|||
|
Name of contact: |
Victoria Whyte |
|
Telephone number of contact: |
020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 10 May 2010
|
Name of applicant: |
GlaxoSmithKline plc |
|||
|
Name of scheme: |
SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - ADS |
|||
|
Period of return: |
From: |
1 November 2009 |
To: |
30 April 2010 |
|
Balance of unallotted securities under scheme(s) from previous return: |
275,420 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
0 |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
0 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
275,420 |
|||
|
Name of contact: |
Victoria Whyte |
|
Telephone number of contact: |
020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 10 May 2010
|
Name of applicant: |
GlaxoSmithKline plc |
|||
|
Name of scheme: |
SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - Ordinary |
|||
|
Period of return: |
From: |
1 November 2009 |
To: |
30 April 2010 |
|
Balance of unallotted securities under scheme(s) from previous return: |
100,000 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
0 |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
0 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
100,000 |
|||
|
Name of contact: |
Victoria Whyte |
|
Telephone number of contact: |
020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 10 May 2010
|
Name of applicant: |
GlaxoSmithKline plc |
|||
|
Name of scheme: |
GlaxoSmithKline Savings Related Share Option Scheme |
|||
|
Period of return: |
From: |
1 November 2009 |
To: |
30 April 2010 |
|
Balance of unallotted securities under scheme(s) from previous return: |
5,191,246 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
0 |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
731,368 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
4,459,878 |
|||
|
Name of contact: |
Victoria Whyte |
|
Telephone number of contact: |
020 8047 5000 |
This information is provided by RNS
Latest directors dealings
- 2 hours ago Molten Ventures
- 2 hours ago Touchstone Exploration Inc NPV (DI)
- 2 hours ago Team Internet Group plc
- 2 hours ago Ondo Insurtech
- 2 hours ago Wilmington